Author

Arnold Pompoš

The University of Texas Southwestern Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Angelica FacoettiiD· 1 shared Anthony J. DavisiD· 1 shared Brock J. SishciD· 1 shared Elizabeth M. AlvesiD· 1 shared Huiming LuiD· 1 shared James H. NicholsoniD· 1 shared Janapriya SahaiD· 1 shared Katy L. SwancuttiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Angelica FacoettiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Defective Homologous Recombination and Genomic Instability Predict Increased Responsiveness to Carbon Ion Radiotherapy in Pancreatic Cancer

Brock J. Sishc, Janapriya Saha, Elizabeth M. Alves, Lianghao Ding, Huiming Lu, Shih-Ya Wang, Katy L. Swancutt, James H. Nicholson, Angelica Facoetti, Arnold Pompoš, Mario Ciocca, Todd Anthony Aguilera, Michael D. Story, Anthony J. Davis

This study identifies PDAC cell lines defective in homologous recombination or with high genomic instability as more responsive to carbon ion radiotherapy, suggesting potential for targeted therapy.

npj Precision Oncology · Jan 17, 2025Peer-reviewedCancer Biology